HEARTWARE® VENTRICULAR ASSIST SYSTEM
Report
- Report Number
- 3007042319-2014-00935
- Event Type
- Malfunction
- Date Received
- September 9, 2014
- Date of Event
- August 19, 2014
- Report Date
- August 19, 2014
- Manufacturer
- HEARTWARE, INC
- Product Code
- DSQ
- PMA / PMN Number
- P100047
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
DEVICE EVALUATED IN THE FIELD BY HEARTWARE CLINICAL ENGINEERING PERSONNEL. THE PRODUCT REMAINS IMPLANTED IN THE PATIENT, THEREFORE IT WILL NOT BE RETURNED. ADDITIONAL INFORMATION WILL BE SUBMITTED WITHIN THIRTY (30) DAYS OF RECEIPT.
THE HEARTWARE VAD IS USED FOR TREATMENT NOT DIAGNOSIS. THE SITE PERFORMED A CLEANING PROCEDURE TO REMOVE THE CONTAMINATION FROM THE DRIVELINE CONNECTOR. THE ORIGINAL CONTROLLER REMAINED IN USE AFTER CLEANING PROCEDURE. DEVICES WERE NOT RETURNED AND THEREFORE A PRODUCT EVALUATION COULD NOT BE PERFORMED. APPLICABLE RISK DOCUMENTATION AND EXPERIENCE WITH EVENTS OF SIMILAR CIRCUMSTANCES WERE CONSIDERED; EVENTS WITH ELECTRICAL FAULTS ARE MANY TIMES ATTRIBUTED TO A FOREIGN MATERIAL CONTAMINATION ON THE DRIVELINE CONNECTOR RESULTING IN A PARTIAL LOSS OF ELECTRICAL CONTINUITY. THE MOST LIKELY ROOT CAUSE OF THE REPORTED ELECTRICAL FAULT EVENT IS AN INGRESS OF CONTAMINATES ONTO THE DRIVELINE CONNECTOR PINS. THE CLINICAL PROCESS AND SUBSEQUENT HANDLING OF THE DRIVELINE MAY HAVE ALLOWED EXTERNAL CONTAMINATES TO ENTER THE DRIVELINE CONNECTOR. THIS DEVICE IS USED FOR TREATMENT NOT DIAGNOSIS. THE VENTRICULAR ASSIST SYSTEM IS INDICATED FOR USE AS A BRIDGE TO CARDIAC TRANSPLANTATION IN PATIENTS WHO ARE AT RISK OF DEATH FROM REFRACTORY END-STAGE LEFT VENTRICULAR HEART FAILURE. THE SYSTEM IS DESIGNED FOR IN-HOSPITAL AND OUT-OF-HOSPITAL SETTINGS. INFORMATION FOR USE (IFU) STATES ABOUT ELECTRICAL FAULTS -A FAULT IN THE CONTINUITY OF THE PUMP TO CONTROLLER ELECTRICAL CONNECTION TRIGGERS THIS ALARM. THE FAULT COULD BE IN THE SYSTEM MOTOR, DRIVELINE AND CONNECTOR OR WITHIN THE CONTROLLER. THE AUDIO PORTION OF THIS ALARM CAN BE PERMANENTLY DISABLED VIA THE MONITOR. WHEN THIS ALARM CONDITION OCCURS, THE SYSTEM PUMP WILL BE RUNNING ON A SINGLE STATOR AND WILL CONSUME SLIGHTLY MORE POWER. THE IFU ALSO PROVIDES INSTRUCTIONS AND SURGICAL TECHNIQUE TO AVOID CONTAMINATION OF THE DRIVELINE. HEARTWARE WILL SUBMIT A SUPPLEMENTAL REPORT WHEN NEW FACTS ARISES WHICH MATERIALLY ALTERS INFORMATION SUBMITTED IN A PREVIOUS MDR REPORT. HEARTWARE IS SUBMITTING THIS REPORT AS A RESULT OF REMEDIATION ACTIVITIES RELATED TO FDA WARNING LETTER FLA-14-14, DATED JUNE 2, 2014, AND PURSUANT TO THE PROVISIONS OF 21 CFR PART 803.
APPROXIMATELY ELEVEN MONTHS AFTER IMPLANT THIS PATIENT EXPERIENCED ELECTRICAL FAULTS ALARMS. INSPECTION OF THE DRIVELINE CONNECTOR BY THE HEARTWARE FIELD SERVICE ENGINEER CONFIRMED CONTAMINATION. A CLEANING PROCEDURE WAS PERFORMED WITH CONTROLLER EXCHANGE. THERE WAS NO INJURY TO THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 553331 | HEARTWARE® VENTRICULAR ASSIST SYSTEM | HEARTWARE® VENTRICULAR ASSIST SYSTEM, DRIVELINE | DSQ | HEARTWARE, INC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | CONTROLLER - (B)(4) |